How many insider trades does FilingIQ track for ADXS?

FilingIQ tracks 393 Form 4 insider transactions for ADXS (Advaxis, Inc.), covering filings from Nov 3, 2014 onwards. 0 of those were filed in the last 90 days.

Are ADXS insiders net buyers or net sellers?

Across the full Form 4 history for ADXS, 16 transactions (4%) were open-market purchases and 42 (11%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ADXS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ADXS in?

Advaxis, Inc. (ADXS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $25.71M.

ADXS insider trading

OTC Markets OTCPK Healthcare

Advaxis, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

393

Last 90 days

Buys / sells

4% / 11%

Market cap

$25.71M

About Advaxis, Inc.

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers in Israel and the United States. The company is developing AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was incorporated in 1987 and is based in Monmouth Junction, New Jersey.

Company website: www.ayalapharma.com

ADXS insider activity at a glance

FilingIQ has scored 393 insider transactions for ADXS since Nov 3, 2014. The most recent filing in our index is dated Feb 7, 2024.

Across the full history, 16 open-market purchases and 42 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ADXS insider trades is 54.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ADXS trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 805

UNITED THERAPEUTICS Corp

BLLN 188

BillionToOne, Inc.

KYMR 166

Kymera Therapeutics, Inc.

THERMO FISHER SCIENTIFIC INC.

HNGE 122

Hinge Health, Inc.

GH 120

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for ADXS?: FilingIQ tracks 393 Form 4 insider transactions for ADXS (Advaxis, Inc.), covering filings from Nov 3, 2014 onwards. 0 of those were filed in the last 90 days.
Are ADXS insiders net buyers or net sellers?: Across the full Form 4 history for ADXS, 16 transactions (4%) were open-market purchases and 42 (11%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ADXS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ADXS in?: Advaxis, Inc. (ADXS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $25.71M.

Methodology & sources

Every ADXS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.